npj Vaccines (Jan 2024)
Author Correction: Co-adjuvanting DDA/TDB liposomes with a TLR7 agonist allows for IgG2a/c class-switching in the absence of Th1 cells
- Julie Zimmermann,
- Simon D. van Haren,
- Joann Diray-Arce,
- Ignatius Ryan Adriawan,
- Katharina Wørzner,
- Ricki T. Krog,
- Safia Guleed,
- Tu Hu,
- Rasmus Mortensen,
- Jes Dietrich,
- Sara M. Ø. Solbak,
- Ofer Levy,
- Dennis Christensen,
- Gabriel K. Pedersen
Affiliations
- Julie Zimmermann
- Center for Vaccine Research, Statens Serum Institut
- Simon D. van Haren
- Precision Vaccines Program, Boston Children’s Hospital
- Joann Diray-Arce
- Precision Vaccines Program, Boston Children’s Hospital
- Ignatius Ryan Adriawan
- Center for Vaccine Research, Statens Serum Institut
- Katharina Wørzner
- Center for Vaccine Research, Statens Serum Institut
- Ricki T. Krog
- Center for Vaccine Research, Statens Serum Institut
- Safia Guleed
- Center for Vaccine Research, Statens Serum Institut
- Tu Hu
- Center for Vaccine Research, Statens Serum Institut
- Rasmus Mortensen
- Center for Vaccine Research, Statens Serum Institut
- Jes Dietrich
- Center for Vaccine Research, Statens Serum Institut
- Sara M. Ø. Solbak
- Department of Drug Design and Pharmacology, University of Copenhagen
- Ofer Levy
- Precision Vaccines Program, Boston Children’s Hospital
- Dennis Christensen
- Center for Vaccine Research, Statens Serum Institut
- Gabriel K. Pedersen
- Center for Vaccine Research, Statens Serum Institut
- DOI
- https://doi.org/10.1038/s41541-024-00804-4
- Journal volume & issue
-
Vol. 9,
no. 1
pp. 1 – 1
Abstract
No abstracts available.
